Nutrition 21 LLC, a subsidiary of JDS Therapeutics LLC, has entered into a confidential settlement and license agreement with SuperNutrition Life-Extension Research, Inc.
The settlement is in regards to a patent and trademark infringement lawsuit against SuperNutrition in the Southern District of New York, claiming SuperNutrition used Nutrition 21’s Chromax trademark and chromium polynicotinate in branded multivitamin products.
While the settlement remains confidential, SuperNutrition will license several Nutrition 21 patents and trademarks and use Nutrition 21 ingredients in its own formulations.
“We are delighted that we were able to reach a customer-driven solution with respect to our dispute with SuperNutrition,” says Gregg Bresner, chief financial officer of Nutrition 21. “SuperNutrition has been an innovative company in the market for decades and we are excited to provide Niachrome to SuperNutrition for use in its branded family of multivitamin products. We believe this reaffirms the strength of Nutrition 21’s trademarks, and its patent portfolio which covers compositions and uses of a number of our products, including our Niachrome chromium polynicotinate.”
